Celsion Corporation (CLSN)

[BioSpecialist]

CLSN IS THE NEXT HOT STOCK !!

Celsion's Technology Is the Focus of 6.4 Million EUR 'HIFU-CHEM' Program To Study ThermoDox(R) and MRI-guided HIFU
Project Will Focus on Early Development and Investigate Treatment Options for Two Indications: Liver and Bone Metastases
http://finance.yahoo.com/news/Celsions-Technology-Is-the-prnews-1680791093.html?x=0&.v=1


Celsion (CLSN)

Market Cap: 35 Mio$
Cash: 14,1 Mio$
Price: 2,90$

Shares Out: 12,1 M



Insider
http://finance.yahoo.com/q/it?s=CLSN


Data Monitoring Committee Recommends Continuation of Celsion's
Phase III ThermoDox(R) Study for Primary Liver Cancer
http://www.celsion.com/releasedetail.cfm?ReleaseID=444013


News
http://www.celsion.com/releases.cfm


Pipeline
http://www.celsion.com/images/Pipeline-Slide-012009.jpg


CEO Letter August 2009
http://www.celsion.com/letter.cfm



Celsion Corporation Announces Exclusive Japan License Agreement with Yakult Honsha for ThermoDox(R)
Dec 15, 2008
http://www.celsion.com/releasedetail.cfm?ReleaseID=354312